Overview
Carvolix, co-founded by Dr. Philippe Pouletty, aims to address the treatment gap in cardiovascular care, where only 17% of patients are eligible for aortic valve replacement and just 5% of stroke victims receive emergency treatment. The company merges cardiovascular implants with AI-driven software and mini-robotics to enhance treatment accessibility. Key investors include Truffle Capital, and the venture is part of a deliberate consolidation strategy to create a unified platform for advanced medical interventions.
Products
Loading...
Recent Deals
Investors: Truffle Capital
Carvolix, co-founded by Dr. Philippe Pouletty, aims to address the treatment gap in cardiovascular care, where only 17% of patients are eligible for aortic valve replacement and just 5% of stroke victims receive emergency treatment. The company merges cardiovascular implants with AI-driven software and mini-robotics to enhance treatment accessibility. Key investors include Truffle Capital, and the venture is part of a deliberate consolidation strategy to create a unified platform for advanced medical interventions.